<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-11-22" modified="2017-12-20" version="164">
<accession>Q9NZC7</accession>
<accession>A8K323</accession>
<accession>Q5MYT5</accession>
<accession>Q96KM3</accession>
<accession>Q96RF2</accession>
<accession>Q9BTT8</accession>
<accession>Q9NPC9</accession>
<accession>Q9NRF4</accession>
<accession>Q9NRF5</accession>
<accession>Q9NRF6</accession>
<accession>Q9NRK1</accession>
<accession>Q9NZC5</accession>
<name>WWOX_HUMAN</name>
<protein>
<recommendedName>
<fullName>WW domain-containing oxidoreductase</fullName>
<ecNumber>1.1.1.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Fragile site FRA16D oxidoreductase</fullName>
</alternativeName>
<alternativeName>
<fullName>Short chain dehydrogenase/reductase family 41C member 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">WWOX</name>
<name type="synonym">FOR</name>
<name type="synonym">SDR41C1</name>
<name type="synonym">WOX1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="2140" last="2145">
<title>WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.</title>
<authorList>
<person name="Bednarek A.K."/>
<person name="Laflin K.J."/>
<person name="Daniel R.L."/>
<person name="Liao Q."/>
<person name="Hawkins K.A."/>
<person name="Aldaz C.M."/>
</authorList>
<dbReference type="PubMed" id="10786676"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-35</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="1651" last="1663">
<title>Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.</title>
<authorList>
<person name="Ried K."/>
<person name="Finnis M."/>
<person name="Hobson L."/>
<person name="Mangelsdorf M."/>
<person name="Dayan S."/>
<person name="Nancarrow J.K."/>
<person name="Woollatt E."/>
<person name="Kremmidiotis G."/>
<person name="Gardner A."/>
<person name="Venter D."/>
<person name="Baker E."/>
<person name="Richards R.I."/>
</authorList>
<dbReference type="PubMed" id="10861292"/>
<dbReference type="DOI" id="10.1093/hmg/9.11.1651"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 173-414</scope>
<scope>CHROMOSOMAL REARRANGEMENT</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="8068" last="8073">
<title>WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.</title>
<authorList>
<person name="Bednarek A.K."/>
<person name="Keck-Waggoner C.L."/>
<person name="Daniel R.L."/>
<person name="Laflin K.J."/>
<person name="Bergsagel P.L."/>
<person name="Kiguchi K."/>
<person name="Brenner A.J."/>
<person name="Aldaz C.M."/>
</authorList>
<dbReference type="PubMed" id="11719429"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="11417" last="11422">
<title>WWOX: a candidate tumor suppressor gene involved in multiple tumor types.</title>
<authorList>
<person name="Paige A.J.W."/>
<person name="Taylor K.J."/>
<person name="Taylor C."/>
<person name="Hillier S.G."/>
<person name="Farrington S."/>
<person name="Scott D."/>
<person name="Porteous D.J."/>
<person name="Smyth J.F."/>
<person name="Gabra H."/>
<person name="Watson J.E.V."/>
</authorList>
<dbReference type="PubMed" id="11572989"/>
<dbReference type="DOI" id="10.1073/pnas.191175898"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1; 3 AND 7)</scope>
<scope>VARIANTS LEU-98; SER-111; TRP-120; THR-179; PHE-272; ALA-282 AND HIS-314</scope>
<scope>INVOLVEMENT IN CANCERS</scope>
</reference>
<reference key="5">
<citation type="submission" date="2004-12" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human WOX8 (WWOX v8).</title>
<authorList>
<person name="Chang N.-S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT THR-179</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="8629" last="8633">
<title>An opposing view on WWOX protein function as a tumor suppressor.</title>
<authorList>
<person name="Watanabe A."/>
<person name="Hippo Y."/>
<person name="Taniguchi H."/>
<person name="Iwanari H."/>
<person name="Yashiro M."/>
<person name="Hirakawa K."/>
<person name="Kodama T."/>
<person name="Aburatani H."/>
</authorList>
<dbReference type="PubMed" id="14695174"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="9195" last="9202">
<title>JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.</title>
<authorList>
<person name="Chang N.-S."/>
<person name="Doherty J."/>
<person name="Ensign A."/>
</authorList>
<dbReference type="PubMed" id="12514174"/>
<dbReference type="DOI" id="10.1074/jbc.M208373200"/>
</citation>
<scope>INTERACTION WITH MAPK8 AND TP53</scope>
<scope>MUTAGENESIS OF LYS-28; ASP-29 AND TYR-33</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Br. J. Cancer" volume="91" first="753" last="759">
<title>Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.</title>
<authorList>
<person name="Park S.-W."/>
<person name="Ludes-Meyers J."/>
<person name="Zimonjic D.B."/>
<person name="Durkin M.E."/>
<person name="Popescu N.C."/>
<person name="Aldaz C.M."/>
</authorList>
<dbReference type="PubMed" id="15266310"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6602023"/>
</citation>
<scope>INVOLVEMENT IN CANCERS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="8256" last="8261">
<title>Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Palamarchuk A."/>
<person name="Weigel R.J."/>
<person name="Herrero J.J."/>
<person name="Pekarsky Y."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="15548692"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-2055"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TFAP2C AND TFAP2A</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Clin. Cancer Res." volume="10" first="2459" last="2465">
<title>The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.</title>
<authorList>
<person name="Kuroki T."/>
<person name="Yendamuri S."/>
<person name="Trapasso F."/>
<person name="Matsuyama A."/>
<person name="Aqeilan R.I."/>
<person name="Alder H."/>
<person name="Rattan S."/>
<person name="Cesari R."/>
<person name="Nolli M.L."/>
<person name="Williams N.N."/>
<person name="Mori M."/>
<person name="Kanematsu T."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="15073125"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-03-0096"/>
</citation>
<scope>INVOLVEMENT IN CANCERS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Clin. Cancer Res." volume="10" first="3053" last="3058">
<title>Loss of WWOX expression in gastric carcinoma.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Kuroki T."/>
<person name="Pekarsky Y."/>
<person name="Albagha O."/>
<person name="Trapasso F."/>
<person name="Baffa R."/>
<person name="Huebner K."/>
<person name="Edmonds P."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="15131042"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-03-0594"/>
</citation>
<scope>INVOLVEMENT IN CANCERS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="5049" last="5055">
<title>WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.</title>
<authorList>
<person name="Ludes-Meyers J.H."/>
<person name="Kil H."/>
<person name="Bednarek A.K."/>
<person name="Drake J."/>
<person name="Bedford M.T."/>
<person name="Aldaz C.M."/>
</authorList>
<dbReference type="PubMed" id="15064722"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207680"/>
</citation>
<scope>INTERACTION WITH LITAF; WBP1; FAM189B AND SCOTIN</scope>
<scope>MUTAGENESIS OF 44-TRP--PRO-47 AND 85-TYR--PRO-88</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="4401" last="4406">
<title>Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Pekarsky Y."/>
<person name="Herrero J.J."/>
<person name="Palamarchuk A."/>
<person name="Letofsky J."/>
<person name="Druck T."/>
<person name="Trapasso F."/>
<person name="Han S.-Y."/>
<person name="Melino G."/>
<person name="Huebner K."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="15070730"/>
<dbReference type="DOI" id="10.1073/pnas.0400805101"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP73</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF TYR-33 AND TYR-61</scope>
<scope>PHOSPHORYLATION AT TYR-33</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="6764" last="6772">
<title>WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Donati V."/>
<person name="Palamarchuk A."/>
<person name="Trapasso F."/>
<person name="Kaou M."/>
<person name="Pekarsky Y."/>
<person name="Sudol M."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="16061658"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-1150"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ERBB4</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="10514" last="10523">
<title>Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.</title>
<authorList>
<person name="Mahajan N.P."/>
<person name="Whang Y.E."/>
<person name="Mohler J.L."/>
<person name="Earp H.S."/>
</authorList>
<dbReference type="PubMed" id="16288044"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-1127"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-287 BY TNK2</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF TYR-287</scope>
<scope>INTERACTION WITH TNK2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="43100" last="43108">
<title>WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.</title>
<authorList>
<person name="Chang N.-S."/>
<person name="Doherty J."/>
<person name="Ensign A."/>
<person name="Schultz L."/>
<person name="Hsu L.-J."/>
<person name="Hong Q."/>
</authorList>
<dbReference type="PubMed" id="16219768"/>
<dbReference type="DOI" id="10.1074/jbc.M505590200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MDM2 AND TP53</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15611" last="15616">
<title>WWOX gene restoration prevents lung cancer growth in vitro and in vivo.</title>
<authorList>
<person name="Fabbri M."/>
<person name="Iliopoulos D."/>
<person name="Trapasso F."/>
<person name="Aqeilan R.I."/>
<person name="Cimmino A."/>
<person name="Zanesi N."/>
<person name="Yendamuri S."/>
<person name="Han S.-Y."/>
<person name="Amadori D."/>
<person name="Huebner K."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="16223882"/>
<dbReference type="DOI" id="10.1073/pnas.0505485102"/>
</citation>
<scope>DISEASE</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="16049" last="16059">
<title>Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.</title>
<authorList>
<person name="Hsu L.-J."/>
<person name="Schultz L."/>
<person name="Hong Q."/>
<person name="Van Moer K."/>
<person name="Heath J."/>
<person name="Li M.-Y."/>
<person name="Lai F.-J."/>
<person name="Lin S.-R."/>
<person name="Lee M.-H."/>
<person name="Lo C.-P."/>
<person name="Lin Y.-S."/>
<person name="Chen S.-T."/>
<person name="Chang N.-S."/>
</authorList>
<dbReference type="PubMed" id="19366691"/>
<dbReference type="DOI" id="10.1074/jbc.M806688200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-33</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HYAL2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="2569" last="2580">
<title>Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.</title>
<authorList>
<person name="Bouteille N."/>
<person name="Driouch K."/>
<person name="Hage P.E."/>
<person name="Sin S."/>
<person name="Formstecher E."/>
<person name="Camonis J."/>
<person name="Lidereau R."/>
<person name="Lallemand F."/>
</authorList>
<dbReference type="PubMed" id="19465938"/>
<dbReference type="DOI" id="10.1038/onc.2009.120"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DVL1; DVL2 AND DVL3</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-12 AND SER-14</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Carcinogenesis" volume="33" first="548" last="554">
<title>A WWOX-binding molecule, transmembrane protein 207, is related to the invasiveness of gastric signet-ring cell carcinoma.</title>
<authorList>
<person name="Takeuchi T."/>
<person name="Adachi Y."/>
<person name="Nagayama T."/>
</authorList>
<dbReference type="PubMed" id="22226915"/>
<dbReference type="DOI" id="10.1093/carcin/bgs001"/>
</citation>
<scope>INTERACTION WITH TMEM207</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Orphanet J. Rare Dis." volume="9" first="12" last="12">
<title>The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration.</title>
<authorList>
<person name="Abdel-Salam G."/>
<person name="Thoenes M."/>
<person name="Afifi H.H."/>
<person name="Koerber F."/>
<person name="Swan D."/>
<person name="Bolz H.J."/>
</authorList>
<dbReference type="PubMed" id="24456803"/>
<dbReference type="DOI" id="10.1186/1750-1172-9-12"/>
</citation>
<scope>INVOLVEMENT IN SCAR12</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="J. Med. Genet." volume="52" first="61" last="70">
<title>WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation.</title>
<authorList>
<person name="Mignot C."/>
<person name="Lambert L."/>
<person name="Pasquier L."/>
<person name="Bienvenu T."/>
<person name="Delahaye-Duriez A."/>
<person name="Keren B."/>
<person name="Lefranc J."/>
<person name="Saunier A."/>
<person name="Allou L."/>
<person name="Roth V."/>
<person name="Valduga M."/>
<person name="Moustaine A."/>
<person name="Auvin S."/>
<person name="Barrey C."/>
<person name="Chantot-Bastaraud S."/>
<person name="Lebrun N."/>
<person name="Moutard M.L."/>
<person name="Nougues M.C."/>
<person name="Vermersch A.I."/>
<person name="Heron B."/>
<person name="Pipiras E."/>
<person name="Heron D."/>
<person name="Olivier-Faivre L."/>
<person name="Gueant J.L."/>
<person name="Jonveaux P."/>
<person name="Philippe C."/>
</authorList>
<dbReference type="PubMed" id="25411445"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2014-102748"/>
</citation>
<scope>INVOLVEMENT IN EIEE28</scope>
<scope>VARIANT EIEE28 ARG-47</scope>
</reference>
<reference key="28">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Solution structure of the second WW domain of WWOX.</title>
<authorList>
<person name="Kowalski K."/>
<person name="Merkel A.L."/>
<person name="Colella A."/>
<person name="Richards R.I."/>
<person name="Booker G.W."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 51-101</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="2258" last="2260">
<title>Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.</title>
<authorList>
<person name="Kuroki T."/>
<person name="Trapasso F."/>
<person name="Shiraishi T."/>
<person name="Alder H."/>
<person name="Mimori K."/>
<person name="Mori M."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="11956080"/>
</citation>
<scope>VARIANT PRO-291</scope>
<scope>INVOLVEMENT IN ESCR</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Brain" volume="137" first="411" last="419">
<title>The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation.</title>
<authorList>
<person name="Mallaret M."/>
<person name="Synofzik M."/>
<person name="Lee J."/>
<person name="Sagum C.A."/>
<person name="Mahajnah M."/>
<person name="Sharkia R."/>
<person name="Drouot N."/>
<person name="Renaud M."/>
<person name="Klein F.A."/>
<person name="Anheim M."/>
<person name="Tranchant C."/>
<person name="Mignot C."/>
<person name="Mandel J.L."/>
<person name="Bedford M."/>
<person name="Bauer P."/>
<person name="Salih M.A."/>
<person name="Schuele R."/>
<person name="Schoels L."/>
<person name="Aldaz C.M."/>
<person name="Koenig M."/>
</authorList>
<dbReference type="PubMed" id="24369382"/>
<dbReference type="DOI" id="10.1093/brain/awt338"/>
</citation>
<scope>VARIANTS SCAR12 THR-47 AND ARG-372</scope>
</reference>
<comment type="function">
<text evidence="3 8 13 17 18 19 21 22">Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm.</text>
</comment>
<comment type="subunit">
<text evidence="3 10 12 13 17 18 19 20 21 22 23">Interacts with TP53, p73/TP73 and MAPK8. Interacts with MAPT/TAU, RUNX2 and HYAL2 (By similarity). Forms a ternary complex with TP53 and MDM2. Interacts with ERBB4, LITAF and WBP1. Interacts with DVL1, DVL2 and DVL3. May interact with FAM189B and SCOTIN. Interacts with TNK2. Interacts with TMEM207.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-12224467">
<id>Q9NYG5-2</id>
<label>ANAPC11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-5234367">
<id>Q67FY2</id>
<label>Bcl9l</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-12809220">
<id>Q5SWW7</id>
<label>C10orf55</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-348169">
<id>P67870</id>
<label>CSNK2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-1188472">
<id>P78358</id>
<label>CTAG1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-724310">
<id>Q15038</id>
<label>DAZAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-641940">
<id>Q60838</id>
<label>Dvl2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-744099">
<id>Q9H0I2</id>
<label>ENKD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-4398741">
<id>Q61527</id>
<label>Erbb4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-6366314">
<id>P81408</id>
<label>FAM189B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-740785">
<id>P49639</id>
<label>HOXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-1052037">
<id>Q8IUC1</id>
<label>KRTAP11-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-12804988">
<id>Q96MT4</id>
<label>LINC01600</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-725647">
<id>Q99732</id>
<label>LITAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-394558">
<id>Q71SY5</id>
<label>MED25</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12040603"/>
<interactant intactId="EBI-2340269">
<id>Q13064</id>
<label>MKRN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-2115556">
<id>Q8N114</id>
<label>SHISA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4320739"/>
<interactant intactId="EBI-3867685">
<id>Q96G27</id>
<label>WBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 13 19 21 22">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11 12 19 21">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Golgi apparatus</location>
</subcellularLocation>
<text evidence="3 11 21">Partially localizes to the mitochondria (PubMed:14695174). Translocates to the nucleus upon genotoxic stress or TNF stimulation (By similarity). Translocates to the nucleus in response to TGFB1 (PubMed:19366691). Isoform 5 and isoform 6 may localize in the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NZC7-1</id>
<name>1</name>
<name>FOR II</name>
<name>FOR2</name>
<name>WWOXv1</name>
<name>WWOX v8</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NZC7-2</id>
<name>2</name>
<name>FOR I</name>
<name>FOR1</name>
<name>WOX2</name>
<name>WWOXv2</name>
<sequence type="described" ref="VSP_016367 VSP_016369"/>
</isoform>
<isoform>
<id>Q9NZC7-3</id>
<name>3</name>
<name>FOR III</name>
<name>FOR3</name>
<name>WOX3</name>
<sequence type="described" ref="VSP_016364 VSP_016365"/>
<text>Variant in position: 182:K->E (found in a primary colorectal tumor and tumor cells).</text>
</isoform>
<isoform>
<id>Q9NZC7-4</id>
<name>4</name>
<name>FOR IV</name>
<sequence type="described" ref="VSP_016358 VSP_016359"/>
</isoform>
<isoform>
<id>Q9NZC7-5</id>
<name>5</name>
<name>WWOXdelta6-8</name>
<name>WWOXv4</name>
<sequence type="described" ref="VSP_016363"/>
</isoform>
<isoform>
<id>Q9NZC7-6</id>
<name>6</name>
<name>WWOXdelta5-8</name>
<name>WWOXv3</name>
<sequence type="described" ref="VSP_016360"/>
</isoform>
<isoform>
<id>Q9NZC7-7</id>
<name>7</name>
<sequence type="described" ref="VSP_016362 VSP_016366"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="5 8">Widely expressed. Strongly expressed in testis, prostate, and ovary. Overexpressed in cancer cell lines. Isoform 5 and isoform 6 may only be expressed in tumor cell lines.</text>
</comment>
<comment type="domain">
<text evidence="12 13 17">The WW 1 domain mediates interaction with TP53, and probably TP73, TFAP2C, LITAF and WBP1.</text>
</comment>
<comment type="PTM">
<text evidence="13 20 21">Phosphorylated upon genotoxic stress. Phosphorylation of Tyr-33 regulates interaction with TP53, TP73 and MAPK8. May also regulate proapoptotic activity. Phosphorylation by TNK2 is associated with polyubiquitination and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="20">Ubiquitinated when phosphorylated by TNK2, leading to its degradation.</text>
</comment>
<comment type="disease">
<text evidence="6 7 14 15 16">Defects in WWOX may be involved in several cancer types. The gene spans the second most common chromosomal fragile site (FRA16D) which is frequently altered in cancers (PubMed:10861292). Alteration of the expression and expression of some isoforms is associated with cancers. However, it is still unclear if alteration of WWOX is directly implicated in cancerogenesis or if it corresponds to a secondary effect (PubMed:10861292, PubMed:11572989, PubMed:15266310, PubMed:15073125, PubMed:15131042).</text>
</comment>
<comment type="disease" evidence="9">
<disease id="DI-01537">
<name>Esophageal cancer</name>
<acronym>ESCR</acronym>
<description>A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.</description>
<dbReference type="MIM" id="133239"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="24 25">
<disease id="DI-04025">
<name>Spinocerebellar ataxia, autosomal recessive, 12</name>
<acronym>SCAR12</acronym>
<description>Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR12 is additionally characterized by onset of generalized seizures in infancy, and delayed psychomotor development with mental retardation. Some patients may also show spasticity.</description>
<dbReference type="MIM" id="614322"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="26">
<disease id="DI-04325">
<name>Epileptic encephalopathy, early infantile, 28</name>
<acronym>EIEE28</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.</description>
<dbReference type="MIM" id="616211"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the short-chain dehydrogenases/reductases (SDR) family.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAP94227" version="1"/>
</conflict>
<location>
<position position="362"/>
</location>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/WWOXID508ch16q23.html"/>
</comment>
<dbReference type="EC" id="1.1.1.-"/>
<dbReference type="EMBL" id="AF211943">
<property type="protein sequence ID" value="AAF27049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF212843">
<property type="protein sequence ID" value="AAF27050.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AH009490">
<property type="protein sequence ID" value="AAF78197.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227526">
<property type="protein sequence ID" value="AAF82053.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227527">
<property type="protein sequence ID" value="AAF82054.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227528">
<property type="protein sequence ID" value="AAF82055.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227529">
<property type="protein sequence ID" value="AAF82056.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF395123">
<property type="protein sequence ID" value="AAK81727.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF395124">
<property type="protein sequence ID" value="AAK81728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325432">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325423">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325424">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325425">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325426">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325427">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325428">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325430">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325431">
<property type="protein sequence ID" value="AAL05449.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325429">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325423">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325424">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325425">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325426">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325427">
<property type="protein sequence ID" value="AAL05450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325432">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325423">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325424">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325425">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325426">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325433">
<property type="protein sequence ID" value="AAL05451.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY256821">
<property type="protein sequence ID" value="AAP94227.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290438">
<property type="protein sequence ID" value="BAF83127.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007445">
<property type="protein sequence ID" value="AAP36113.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003184">
<property type="protein sequence ID" value="AAH03184.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42196.1">
<molecule id="Q9NZC7-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42197.1">
<molecule id="Q9NZC7-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001278926.1">
<property type="nucleotide sequence ID" value="NM_001291997.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057457.1">
<molecule id="Q9NZC7-1"/>
<property type="nucleotide sequence ID" value="NM_016373.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_570607.1">
<molecule id="Q9NZC7-3"/>
<property type="nucleotide sequence ID" value="NM_130791.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.461453"/>
<dbReference type="PDB" id="1WMV">
<property type="method" value="NMR"/>
<property type="chains" value="A=51-101"/>
</dbReference>
<dbReference type="PDBsum" id="1WMV"/>
<dbReference type="ProteinModelPortal" id="Q9NZC7"/>
<dbReference type="SMR" id="Q9NZC7"/>
<dbReference type="BioGrid" id="119707">
<property type="interactions" value="252"/>
</dbReference>
<dbReference type="IntAct" id="Q9NZC7">
<property type="interactions" value="96"/>
</dbReference>
<dbReference type="MINT" id="MINT-1175612"/>
<dbReference type="STRING" id="9606.ENSP00000457230"/>
<dbReference type="iPTMnet" id="Q9NZC7"/>
<dbReference type="PhosphoSitePlus" id="Q9NZC7"/>
<dbReference type="BioMuta" id="WWOX"/>
<dbReference type="DMDM" id="74725363"/>
<dbReference type="EPD" id="Q9NZC7"/>
<dbReference type="MaxQB" id="Q9NZC7"/>
<dbReference type="PaxDb" id="Q9NZC7"/>
<dbReference type="PeptideAtlas" id="Q9NZC7"/>
<dbReference type="PRIDE" id="Q9NZC7"/>
<dbReference type="DNASU" id="51741"/>
<dbReference type="Ensembl" id="ENST00000355860">
<molecule id="Q9NZC7-3"/>
<property type="protein sequence ID" value="ENSP00000348119"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402655">
<molecule id="Q9NZC7-6"/>
<property type="protein sequence ID" value="ENSP00000384238"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406884">
<molecule id="Q9NZC7-5"/>
<property type="protein sequence ID" value="ENSP00000384495"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000408984">
<molecule id="Q9NZC7-2"/>
<property type="protein sequence ID" value="ENSP00000386161"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000566780">
<molecule id="Q9NZC7-1"/>
<property type="protein sequence ID" value="ENSP00000457230"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000569818">
<molecule id="Q9NZC7-4"/>
<property type="protein sequence ID" value="ENSP00000454485"/>
<property type="gene ID" value="ENSG00000186153"/>
</dbReference>
<dbReference type="GeneID" id="51741"/>
<dbReference type="KEGG" id="hsa:51741"/>
<dbReference type="UCSC" id="uc002ffi.3">
<molecule id="Q9NZC7-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="51741"/>
<dbReference type="DisGeNET" id="51741"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186153.16"/>
<dbReference type="GeneCards" id="WWOX"/>
<dbReference type="HGNC" id="HGNC:12799">
<property type="gene designation" value="WWOX"/>
</dbReference>
<dbReference type="HPA" id="HPA050992"/>
<dbReference type="MalaCards" id="WWOX"/>
<dbReference type="MIM" id="133239">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="605131">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614322">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616211">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NZC7"/>
<dbReference type="OpenTargets" id="ENSG00000186153"/>
<dbReference type="Orphanet" id="251510">
<property type="disease" value="46,XY partial gonadal dysgenesis"/>
</dbReference>
<dbReference type="Orphanet" id="284282">
<property type="disease" value="Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37398"/>
<dbReference type="eggNOG" id="ENOG410INSS">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5021">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119068"/>
<dbReference type="HOVERGEN" id="HBG078800"/>
<dbReference type="InParanoid" id="Q9NZC7"/>
<dbReference type="KO" id="K19329"/>
<dbReference type="OMA" id="AATSIYC"/>
<dbReference type="OrthoDB" id="EOG091G0EI5"/>
<dbReference type="PhylomeDB" id="Q9NZC7"/>
<dbReference type="TreeFam" id="TF105428"/>
<dbReference type="Reactome" id="R-HSA-1251985">
<property type="pathway name" value="Nuclear signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866904">
<property type="pathway name" value="Negative regulation of activity of TFAP2 (AP-2) family transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866907">
<property type="pathway name" value="Activation of the TFAP2 (AP-2) family of transcription factors"/>
</dbReference>
<dbReference type="SignaLink" id="Q9NZC7"/>
<dbReference type="SIGNOR" id="Q9NZC7"/>
<dbReference type="ChiTaRS" id="WWOX">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9NZC7"/>
<dbReference type="GeneWiki" id="WWOX"/>
<dbReference type="GenomeRNAi" id="51741"/>
<dbReference type="PRO" id="PR:Q9NZC7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186153"/>
<dbReference type="ExpressionAtlas" id="Q9NZC7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NZC7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription factor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050662">
<property type="term" value="F:coenzyme binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048037">
<property type="term" value="F:cofactor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016491">
<property type="term" value="F:oxidoreductase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072332">
<property type="term" value="P:intrinsic apoptotic signaling pathway by p53 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030178">
<property type="term" value="P:negative regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055114">
<property type="term" value="P:oxidation-reduction process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001238">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001241">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048705">
<property type="term" value="P:skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00201">
<property type="entry name" value="WW"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002347">
<property type="entry name" value="SDR_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR001202">
<property type="entry name" value="WW_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036020">
<property type="entry name" value="WW_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00106">
<property type="entry name" value="adh_short"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00397">
<property type="entry name" value="WW"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00081">
<property type="entry name" value="GDHRDH"/>
</dbReference>
<dbReference type="SMART" id="SM00456">
<property type="entry name" value="WW"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51045">
<property type="entry name" value="SSF51045"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01159">
<property type="entry name" value="WW_DOMAIN_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50020">
<property type="entry name" value="WW_DOMAIN_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="WW domain-containing oxidoreductase" id="PRO_0000054815">
<location>
<begin position="1"/>
<end position="414"/>
</location>
</feature>
<feature type="domain" description="WW 1" evidence="4">
<location>
<begin position="16"/>
<end position="49"/>
</location>
</feature>
<feature type="domain" description="WW 2" evidence="4">
<location>
<begin position="57"/>
<end position="90"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="3">
<location>
<begin position="131"/>
<end position="137"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MAPT" evidence="3">
<location>
<begin position="125"/>
<end position="414"/>
</location>
</feature>
<feature type="region of interest" description="Mediates targeting to the mitochondria" evidence="3">
<location>
<begin position="209"/>
<end position="273"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="3">
<location>
<begin position="50"/>
<end position="55"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="3">
<location>
<position position="293"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3">
<location>
<position position="260"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="13 21">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by TNK2" evidence="20">
<location>
<position position="287"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_016358" evidence="28">
<original>N</original>
<variation>K</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_016359" evidence="28">
<location>
<begin position="37"/>
<end position="414"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_016360" evidence="29">
<original>GFETAKSFALHGAHVILACRNMARASEAVSRILEEWHKAKVEAMTLDLALLRSVQHFAEAFKAKNVPLHVLVCNAATFALPWSLTKDGLETTFQVNHLGHFYLVQLLQDVLCRSAPARVIVVSSESHRFTDINDSLGKLDFSRLSPTKNDYWAMLAYNRSKLCNILFSNELHRRLSPRGVTSNAVHPGNMMYSNIHRSWWVYTLLFTLARPFTKSMQQGAATTVYCAAVPELEGLGGMYFNNCCRCMPSPEAQSEETARTLWALSERLIQERLGSQSG</original>
<variation>ATGSCHHRVLCCCPRTGGSGRDVLQQLLPLHALTRSSERRDGPDPVGAQREADPRTAWQPVRLSGAQSGWAHTPALCVSPHASARAGPLPNVPPTQIRKSKGNKSSHNRVKNLKYQWEAGNSWGKVSLFWGWARHRSLCFLVVACLKVKTCLVCRFRISLEKHQQFSFFYCYRIA</variation>
<location>
<begin position="137"/>
<end position="414"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_016362" evidence="32">
<original>FETAKSFALHGAHVILACRNMARASEAVSRILEEWHKAKVEAMTLDLALLRSVQHFAEAFKAKNVPLHVLVCNAAT</original>
<variation>KASCHVGRTLKHTRVEELSLLPTAINRELPPPCTVLLSQNWRVWEGCTSTTAAAACPHQKLRAKRRPGPCGRSARG</variation>
<location>
<begin position="138"/>
<end position="213"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_016363" evidence="29 30 31">
<location>
<begin position="173"/>
<end position="352"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_016364" evidence="28">
<original>HKAKVEAMTLDLALLRS</original>
<variation>KTKYHPPPEKCRIKIFH</variation>
<location>
<begin position="173"/>
<end position="189"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_016365" evidence="28">
<location>
<begin position="190"/>
<end position="414"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_016366" evidence="32">
<location>
<begin position="214"/>
<end position="414"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_016367" evidence="28">
<original>QQGAATTVYCA</original>
<variation>VSDCLVEGGHF</variation>
<location>
<begin position="353"/>
<end position="363"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_016369" evidence="28">
<location>
<begin position="364"/>
<end position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE28; dbSNP:rs730880292." id="VAR_072351" evidence="26">
<original>P</original>
<variation>R</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR12; dbSNP:rs587777128." id="VAR_070992" evidence="24">
<original>P</original>
<variation>T</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs144601717." id="VAR_023916" evidence="7">
<original>P</original>
<variation>L</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma cell line; dbSNP:rs114755364." id="VAR_023917" evidence="7">
<original>T</original>
<variation>S</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In a primary colorectal tumor and a histiocytic lymphoma cell line; dbSNP:rs141361080." id="VAR_023918" evidence="7">
<original>R</original>
<variation>W</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11545029." id="VAR_023919" evidence="7 27">
<original>A</original>
<variation>T</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7201683." id="VAR_052323">
<original>L</original>
<variation>V</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs186745328." id="VAR_023920" evidence="7">
<original>L</original>
<variation>F</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3764340." id="VAR_023921" evidence="7">
<original>P</original>
<variation>A</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a esophageal cancer sample; somatic mutation; dbSNP:rs119487098." id="VAR_023922" evidence="9">
<original>L</original>
<variation>P</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In a cervical carcinoma cell line; dbSNP:rs73572838." id="VAR_023923" evidence="7">
<original>R</original>
<variation>H</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR12; dbSNP:rs587777127." id="VAR_070993" evidence="24">
<original>G</original>
<variation>R</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TP53. Abolishes interaction with MAPK8; when associated with V-29." evidence="10">
<original>K</original>
<variation>T</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TP53. Abolishes interaction with MAPK8; when associated with T-28." evidence="10">
<original>D</original>
<variation>V</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation." evidence="10 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." evidence="10 13">
<original>Y</original>
<variation>R</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with LITAF." evidence="12">
<original>WEHP</original>
<variation>FEHA</variation>
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TP73." evidence="13">
<original>Y</original>
<variation>R</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with LITAF." evidence="12">
<original>YLDP</original>
<variation>ALDA</variation>
<location>
<begin position="85"/>
<end position="88"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by TNK2." evidence="20">
<original>Y</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="73"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="86"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WMV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00224"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10786676"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10861292"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11572989"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719429"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11956080"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12514174"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14695174"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15064722"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15070730"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15073125"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15131042"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15266310"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15548692"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16061658"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16219768"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16288044"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19366691"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19465938"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22226915"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24369382"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24456803"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25411445"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10861292"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11719429"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="414" mass="46677" checksum="E4D9A649E6CB05DF" modified="2000-10-01" version="1">
MAALRYAGLDDTDSEDELPPGWEERTTKDGWVYYANHTEEKTQWEHPKTGKRKRVAGDLP
YGWEQETDENGQVFFVDHINKRTTYLDPRLAFTVDDNPTKPTTRQRYDGSTTAMEILQGR
DFTGKVVVVTGANSGIGFETAKSFALHGAHVILACRNMARASEAVSRILEEWHKAKVEAM
TLDLALLRSVQHFAEAFKAKNVPLHVLVCNAATFALPWSLTKDGLETTFQVNHLGHFYLV
QLLQDVLCRSAPARVIVVSSESHRFTDINDSLGKLDFSRLSPTKNDYWAMLAYNRSKLCN
ILFSNELHRRLSPRGVTSNAVHPGNMMYSNIHRSWWVYTLLFTLARPFTKSMQQGAATTV
YCAAVPELEGLGGMYFNNCCRCMPSPEAQSEETARTLWALSERLIQERLGSQSG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>